In the United States, we usually think
of patent litigation as a federal court practice. However, significant patent
issues can arise in IP-related state law claims. One question that arises
frequently is whether those issues should be tried in state courts or federal
court. Although the Supreme Court’s 2013 ruling in Gunn v. Minton, ___ U.S. ___, 133 S. Ct. 1059 (2013) restricted the
types of state-law claims that are subject to federal court jurisdiction, the
Federal Circuit may be poised to reassert jurisdiction to avoid potentially
conflicting rulings in state and federal forums.
Federal Jurisdiction Under the Gunn
The federal courts exercise exclusive subject matter
jurisdiction over claims for relief “arising under any Act of Congress relating
to patents[.]” 28 U.S.C. § 1338(a). In the past, in addition to typical patent
infringement actions, federal courts exercised “arising under” jurisdiction to
a variety of state-law claims, including suits alleging breach of patent
license agreements, defamation, and legal malpractice.
In Gunn, the Court
held that a state-law claim “arises” under the Patent Act if patent issue
implicated in a claim is: (1) necessarily raised, (2) actually disputed, (3)
substantial, and (4) capable of resolution in federal court without disrupting
the federal-state balance approved by Congress. Of particular importance is the
requirement that the issue be “substantial.” As Gunn explained, it is not enough for the issue to be important to
the outcome of the claim. Instead, an issue is substantial only if it is
important “to the federal system as a whole.”
The state-law action in Gunn
was for legal malpractice. The defendant attorney allegedly neglected to raise
an argument in a patent infringement action that would have rebutted an alleged
infringer’s argument that the patent was invalid due to a statutory bar. The
Supreme Court held that while that argument was pivotal to the success of the
malpractice claim, its “backward-looking” nature prevented federal
jurisdiction:
Because of the backward-looking nature of a legal malpractice claim, the question is posed in a merely hypothetical sense: If Minton’s lawyers had raised a timely experimental-use argument, would the result in the patent infringement proceeding have been different? No matter how the state courts resolve that hypothetical “case within a case,” it will not change the real-world result of the prior federal patent litigation. Minton’s patent will remain invalid.
133 S. Ct. at 1068. For a more lengthy comment on Gunn, see “Gunn v. Minton: Supreme Court Pokes Another Hole In Exclusive Federal Jurisdiction Over Patent Rights,” SSRN No. 2232879 (Mar. 13, 2013).
Courts Apply Gunn To Expand State Court Jurisdiction
In applying Gunn,
courts have focused on whether the patent law issue to be decided in the action
is “backward-looking” or forward-looking. In other words, does the issue only
relate to the state-law claim, or could it affect patent rights in future
cases?
In Forrester
Environmental Services, Inc. v. Wheelabrator Tech., Inc., 715 F.3d 1329
(Fed. Cir. 2013), the Federal Circuit applied Gunn to decline federal jurisdiction over a state court defamation
action based on the defendant’s statements that the plaintiff was infringing
three patents. The court noted that pre-Gunn
cases in which it had recognized jurisdiction over disparagement claims “may
well have survived the Supreme Court’s decision in Gunn.” 715 F.3d at 1334. Forrester’s claim did not survive,
however, because any state court rulings on the scope or infringement of the
patents would have no forward-looking affect: The patents all had expired and
the defamatory statements referenced conduct in Taiwan, which would not be
infringement in any event.
Like the Federal Circuit in Forrester, the majority of courts applying Gunn have failed to
recognize federal question jurisdiction. However, unlike Forrester, many of those involved patents which are not invalid or
expired. The courts tend to brush aside patentee arguments that any
determination of patent law issues could have future preclusive effects.
In MDS (Canada) Inc.
v. Rad Source Techs., Inc., 720 F.3d 833 (11th Cir. 2013), the court ruled
that the Federal Circuit lacked appellate jurisdiction over a breach of license
dispute that turned on whether the licensee’s product infringed three patents.
The court held that the issue of patent infringement was not substantial.
Notably, the court stated that infringement of the patent was not a substantial
issue because, “Both the highly specialized nature of patent claims and the
niche market for [the accused] blood irradiation devices suggest that the
resolution of this issue is unlikely to impact any future construction of claims.”
720 F.3d at 842. The court did not mention that the licensed patents do not
expire until 2022.
A review of other decisions applying Gunn reveal that courts have interpreted it to broadly discourage
federal jurisdiction even when the underlying claim involves the validity or
infringement of “live” patents. See,
e.g., Bonnafant v. Chico’s FAS, Inc., Case No. 2:13-CV-893-FTM-29CM, 2014
WL 1664554 (M.D. Fla. Apr. 25, 2014) (whistleblower case lacked federal
question jurisdiction when issue whether employee was instructed in infringe
patent “will hardly call into question the entire federal trademark/patent
system. Instead, it will require the application of a set body of law to the
facts at hand.”); Airwatch LLC v. Good
Technology Corp., No. 1:13-cv-2870-WSD, 2014 WL 1651964 (N.D. Ga. Apr. 24,
2014) (no federal jurisdiction over defamation action because infringement
issue was “context-specific”); Transcardiac
Therapeutics, Inc. v. Yoganathan, No. 1:13-CV-3089-AT, 2014 WL 1624086
(N.D. Ga. Feb. 28, 2014) (breach of contract, interference and fraud claims
involving inventorship dispute lack federal question where inventorship was
“not substantial in any relevant sense”).
Jang v. Boston Scientific: The Fed. Cir. Strikes Back?
More recently, the Federal Circuit has signaled that federal
jurisdiction may continue over state-law claims in similar circumstances. In Jang v. Boston Scientific Corp., No.
2014-134, 2014 WL 4746002 (Fed. Cir. Sept. 16, 2014), the court considered
whether it had appellate jurisdiction over a patent license dispute. The
appeals court distinguished Forrester and
stressed the risks of allowing other courts to rule on patent validity or
infringement:
Permitting regional circuits to adjudicate questions of patent validity, for example, could result in inconsistent judgments between a regional circuit and the Federal Circuit, resulting in serious uncertainty for parties facing similar infringement charges before district courts within that regional circuit. Maintaining Federal Circuit jurisdiction over such contractual disputes to avoid such conflicting rulings is important to “the federal system as a whole” and not merely “to the particular parties in the immediate suit.” Gunn, 133 S.Ct. at 1066.
Jang, 2014 WL 4746002 at *3. As a result, the appeals court ruled that the patent issues raised by Jang’s breach of license claim were substantial and triggered “arising under” jurisdiction. This was true even though Jang’s patent had been invalidated as a result of reexamination proceeding. The Federal Circuit reasoned that jurisdiction must be assessed at the time an action is commenced, and since the patent only was invalidated later, federal jurisdiction attached to Jang’s claim.
The Jang decision
suggests that the Federal Circuit, the regional circuit courts of appeals, and
potentially state courts will continue to struggle with jurisdiction over
patent issues arising in the context of state-law claims. Despite broad
language in Gunn, it is likely that
the Federal Circuit will tend to find jurisdiction in cases involving patents
which remain in effect and where the application of patent law may affect
future market activity or be the subject of future litigation.
No comments:
Post a Comment